Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 300: FFRCT Derived Coronary Physiological Pattern and Graft Patency in the FASTTRACK CABG Trial

Presenter: TsungYing Tsai

October 29, 2024

Presentation TCT 2024

TCT 294: Graft Patency After Quantitative Flow Ratio-Guided Coronary Artery Bypass Grafting: Multicenter Historical Cohort Study

Presenter: Masafumi Nakayama

October 28, 2024

Presentation TCT 2024

TCT 291: Impact of Preoperative Quantitative Flow Ratio on Long Term Coronary Artery Bypass Grafts Patency

Presenter: Judit Andréka

October 28, 2024

News Conference News ESC 2024

No Go for No-Touch SVG Harvesting in CABG Surgery: SWEDEGRAFT

Michael O'Riordan

August 31, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

Michael O'Riordan

July 11, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Caitlin E. Cox

April 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Advertisement

Top Endovascular News of 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 300: FFRCT Derived Coronary Physiological Pattern and Graft Patency in the FASTTRACK CABG Trial

TCT 294: Graft Patency After Quantitative Flow Ratio-Guided Coronary Artery Bypass Grafting: Multicenter Historical Cohort Study

TCT 291: Impact of Preoperative Quantitative Flow Ratio on Long Term Coronary Artery Bypass Grafts Patency

No Go for No-Touch SVG Harvesting in CABG Surgery: SWEDEGRAFT

What’s Going to Be Hot at ESC 2024

Prior Transradial Cath Shouldn’t Mean Radial Graft a No-go for Surgery

TCTMD’s Top 10 Most Popular Stories for June 2024

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content